HK1047437B - Gonadotropin releasing hormone receptor antagonists and their related methods of use - Google Patents

Gonadotropin releasing hormone receptor antagonists and their related methods of use Download PDF

Info

Publication number
HK1047437B
HK1047437B HK02109095.3A HK02109095A HK1047437B HK 1047437 B HK1047437 B HK 1047437B HK 02109095 A HK02109095 A HK 02109095A HK 1047437 B HK1047437 B HK 1047437B
Authority
HK
Hong Kong
Prior art keywords
methyl
substituted
compound
pyrimid
fluorobenzyl
Prior art date
Application number
HK02109095.3A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1047437A1 (en
Inventor
Zhu Yun-Fei
D. Gross Timothy
Gao Yinghong
J. Connors Patrick Jr.
Guo Zhiqiang
Chen Chen
Original Assignee
Neurocrine Biosciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences, Inc. filed Critical Neurocrine Biosciences, Inc.
Publication of HK1047437A1 publication Critical patent/HK1047437A1/en
Publication of HK1047437B publication Critical patent/HK1047437B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK02109095.3A 1999-10-15 2000-10-16 Gonadotropin releasing hormone receptor antagonists and their related methods of use HK1047437B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41876899A 1999-10-15 1999-10-15
US418768 1999-10-15
PCT/US2000/028677 WO2001029044A1 (en) 1999-10-15 2000-10-16 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Publications (2)

Publication Number Publication Date
HK1047437A1 HK1047437A1 (en) 2003-02-21
HK1047437B true HK1047437B (en) 2005-12-16

Family

ID=23659500

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02109095.3A HK1047437B (en) 1999-10-15 2000-10-16 Gonadotropin releasing hormone receptor antagonists and their related methods of use

Country Status (11)

Country Link
EP (1) EP1220857B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003512379A (cg-RX-API-DMAC7.html)
KR (1) KR20020045609A (cg-RX-API-DMAC7.html)
AT (1) ATE305008T1 (cg-RX-API-DMAC7.html)
AU (1) AU769855B2 (cg-RX-API-DMAC7.html)
CA (1) CA2386942A1 (cg-RX-API-DMAC7.html)
DE (1) DE60022769T2 (cg-RX-API-DMAC7.html)
ES (1) ES2249302T3 (cg-RX-API-DMAC7.html)
HK (1) HK1047437B (cg-RX-API-DMAC7.html)
MX (1) MXPA02003614A (cg-RX-API-DMAC7.html)
WO (1) WO2001029044A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608197B2 (en) 2000-01-25 2003-08-19 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
ES2307760T3 (es) 2001-04-30 2008-12-01 Aterna Zentaris Gmbh Tratamiento de la demencia y enfermedades neurodegenerativas con dosis intermedias de antagonistas de lhrh.
EP1412363A1 (en) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists
EP1414808A1 (en) 2001-08-02 2004-05-06 Neurocrine Biosciences, Inc. 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists
JP2005504034A (ja) 2001-08-02 2005-02-10 ニューロクライン バイオサイエンシーズ, インコーポレイテッド ゴナドトロピン放出性ホルモンレセプターアンタゴニストとしてのピリジノン誘導体およびピリダジノン誘導体
JP2005505525A (ja) * 2001-08-02 2005-02-24 ニューロクライン バイオサイエンシーズ, インコーポレイテッド 性腺刺激ホルモン放出ホルモンレセプターアンタゴニストおよびそれに関連する方法
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
WO2003068769A1 (en) 2002-02-12 2003-08-21 Pfizer Inc. Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
JP2005538064A (ja) 2002-06-13 2005-12-15 ファイザー・インク 非ペプチドGnRH剤、医薬組成物、およびそれらの使用方法
JP4673847B2 (ja) 2003-07-07 2011-04-20 ニューロクライン バイオサイエンシーズ,インコーポレイテッド 性腺刺激ホルモン放出ホルモンレセプターアンタゴニストおよびそれに関連する方法
BRPI0412327A (pt) 2003-07-07 2006-09-05 Neurocrine Biosciences Inc derivados de pirimidina-2,4-diona como antagonistas de receptor de hormÈnio liberador de gonadotropina
EP1646389B1 (en) 2003-07-07 2008-09-10 Neurocrine Biosciences, Inc. Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
MX2009010828A (es) 2007-04-06 2009-10-29 Neurocrine Biosciences Inc Antagonistas del receptor de la hormona liberadora de gonadotropina y metodos relacionados con los mismos.
CL2008000986A1 (es) 2007-04-06 2008-10-17 Neurocrine Biosciences Inc COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
ES2422741T3 (es) * 2007-12-13 2013-09-13 Vertex Pharma Moduladores del regulador de la conductancia transmembrana de la fibrosis quística
CN101987865B (zh) * 2009-07-29 2014-07-30 中国人民解放军军事医学科学院毒物药物研究所 含有乙内酰脲结构的促黄体生成素释放激素拮抗剂
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
WO2012175514A1 (en) 2011-06-21 2012-12-27 Bayer Intellectual Property Gmbh Pyridinone derivatives and pharmaceutical compositions thereof
US9481684B2 (en) * 2012-02-28 2016-11-01 Sk Chemicals Co., Ltd. Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same
US20160002247A1 (en) * 2013-03-01 2016-01-07 The University Of Tokyo 8-substituted imidazopyrimidinone derivative having autotaxin inhibitory activity
KR101973074B1 (ko) * 2018-11-30 2019-04-26 주식회사 티움바이오 퓨로피리미딘 화합물의 염 및 결정형, 및 이를 포함하는 약학적 조성물
JP7254246B2 (ja) 2019-11-25 2023-04-07 アムジエン・インコーポレーテツド デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194419B1 (en) * 1997-12-26 2001-02-27 Takeda Chemical Industries, Ltd. Nitrogen-containing heterocyclic compounds, their production and use
US6081508A (en) * 1998-02-25 2000-06-27 Indus River Networks, Inc. Remote computer communication
EP1067930A4 (en) * 1998-04-02 2002-09-18 Merck & Co Inc GONADOLIBER'S ANTAGONISTS

Also Published As

Publication number Publication date
CA2386942A1 (en) 2001-04-26
ATE305008T1 (de) 2005-10-15
EP1220857A1 (en) 2002-07-10
AU1208901A (en) 2001-04-30
DE60022769D1 (de) 2006-02-02
MXPA02003614A (es) 2002-10-23
ES2249302T3 (es) 2006-04-01
AU769855B2 (en) 2004-02-05
JP2003512379A (ja) 2003-04-02
WO2001029044A1 (en) 2001-04-26
HK1047437A1 (en) 2003-02-21
DE60022769T2 (de) 2006-07-06
KR20020045609A (ko) 2002-06-19
EP1220857B1 (en) 2005-09-21

Similar Documents

Publication Publication Date Title
EP1220857B1 (en) Gonadotropin releasing hormone receptor antagonists and their related methods of use
JP4931314B2 (ja) 性腺刺激ホルモン放出ホルモンレセプタアンタゴニストおよびそれに関連した方法
US6921761B2 (en) Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
EP1412338B1 (en) 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
AU767440B2 (en) Imidazo- and pyrrolo(1,2-A)pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
US6346534B1 (en) Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
EP1644342B1 (en) Arylpyrimidines useful for the treatment of sex hormone-related conditions such as endometriosis, prostate cancer and the like
US6951858B2 (en) Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
US6740656B2 (en) Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
US6537998B1 (en) Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
US20040142942A1 (en) Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
AU2002321864A1 (en) 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (GNRH) antagonists

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091016